Foster City based Applied Biosystems announced last Tuesday that it has signed an agreement with Eagle Research and Development LLC in which the parties agreed to collaborate on a single molecule detection device developed by Eagle.  Applied Biosystems reported that it has received an exclusive two year option to license the technology.

According to the San Jose Business Journal:

"Eagle’s technology, currently in prototype stage, identifies and quantifies molecules based on their unique electronic charge signatures. Applied Biosystems said the technology could have significant implications for advancing personalized medicine based on its potential for faster, more efficient and less expensive protein and nucleic acid identification, protein-protein and protein/small molecule interaction measurements, and DNA sequencing."